Biosynex laboratory announces the promotion of Oren Bitton to the position of Group Executive Vice President.

Oren Bitton joined Biosynex in 2011. He was appointed Director of the
Business Unit (BU) Pharma in September 2022, where he structured and developed the business, ensuring the post-Covid transition and bringing in international growth prospects.

Oren Bitton will be supported by Thierry Paper (Co-founder), who will retain his position as Scientific Director and take charge of US operations.

In addition, the Board of Directors will propose to the Annual General Meeting of Shareholders on June 7, the appointment of Brigitte Geny as an independent Director of the company, and the appointment of Diane Abensur as a Director.

Copyright (c) 2024 CercleFinance.com. All rights reserved.